Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51,177	50,141	78,348	85,441	97,444	112,394
Market Cap Growth	-33.95%	-36.00%	-8.30%	-12.32%	-13.30%	43.25%
Enterprise Value	25,493	30,087	41,605	53,950	71,749	92,548
Last Close Price	4690.00	4595.00	6935.57	7403.88	8254.97	9339.95
PE Ratio	112.73	16.74	-	7.24	10.78	15.27
PS Ratio	0.77	0.69	0.96	1.07	1.31	1.68
PB Ratio	0.66	0.64	1.02	1.01	1.27	1.59
P/TBV Ratio	0.67	0.64	1.02	1.01	1.27	1.60
P/FCF Ratio	5.04	13.05	-	-	12.72	9.70
P/OCF Ratio	4.64	10.30	-	14.45	11.07	9.12
EV/Sales Ratio	0.38	0.41	0.51	0.68	0.96	1.39
EV/EBITDA Ratio	8.03	4.87	4.91	3.43	5.63	7.47
EV/EBIT Ratio	22.50	7.33	6.19	3.77	6.37	8.38
EV/FCF Ratio	2.51	7.83	-	-	9.37	7.98
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.01	0.01	0.01	0.00	0.00
Debt / FCF Ratio	0.01	0.02	-	-	0.01	0.00
Asset Turnover	0.71	0.82	0.88	0.87	0.87	0.84
Inventory Turnover	1.73	2.01	2.74	3.41	3.67	3.37
Quick Ratio	4.30	5.81	4.52	7.81	5.51	5.13
Current Ratio	6.43	8.73	6.41	9.80	6.82	6.44
Return on Equity (ROE)	0.57%	3.86%	-6.08%	14.63%	12.26%	10.83%
Return on Assets (ROA)	0.76%	2.87%	4.56%	9.78%	8.19%	8.67%
Return on Capital (ROIC)	0.91%	3.30%	5.19%	11.09%	9.54%	10.14%
Return on Capital Employed (ROCE)	1.40%	5.00%	8.40%	16.50%	14.40%	15.00%
Earnings Yield	0.87%	5.97%	-6.28%	13.82%	9.28%	6.55%
FCF Yield	19.84%	7.66%	-2.71%	-0.21%	7.86%	10.31%
Payout Ratio	386.80%	54.02%	-	15.52%	18.07%	14.80%
Buyback Yield / Dilution	0.28%	-0.08%	0.01%	1.30%	-0.56%	0.33%

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.